全球醫療相關企業各研發階段間的合作：2006 年版 第四卷 是由出版商Pharmalicensing Ltd.在2006年02月所出版的。
這份英文市場調查報告書包含1386 pages 價格從美金2495起跳。
2005 年生技藥物領域的企業合併與吸收持續進展，件數達到 230 件，較 2004、2003 年的 170、150 件都來得多。
專研製藥、生技、保健領域，素有好評的英國市調公司 Bridgehead International Limited（總公司：英國雷斯塔夏），調查分析了 2005 年全球醫療相關企業間各研發階段的合作狀況後，出版了一本綜合報告書 "Partneringreview 2006 - Stage of development(volume 4)"。
本報告書為全系列六卷中的第四卷，內容包含 2005 年所發表，超過 2600 件的醫藥企業的各研發階段合作，以企業、治療領域、研發階段分類，內容綱要摘記如下：
第1章 初期階段：藥物研發、臨床前
第2章 臨床階段：Phase I∼Phase III
第3章 後期階段：登錄、市場拓展
第4章 合作列表
用語
調查對象（舉例）
- Pfizer
- GlaxoSmithKline
- Sanofi-Aventis
- Johnson & Johnson
- Merck
- Novartis
- AstraZeneca
- Roche
- Bristol-Myers Squibb
- Wyeth
- Abbott Labs
- Eli Lilly
- Amgen
- 武田藥品工業
- Boehringer Ingelheim
- Schering-Plough
- Schering AG
- Bayer
- Eisai
- Teva
- Merck KGaA
- Yamanouchi（今 Astellas）
- 大塚製藥
- Novo Nordisk
- Baxter
- Fujisawa（今 Astellas）
- 三共
- Forest Labs
- Akzo Nobel
- Altana
- Serono
- Solvay
- UCB
- Genzyme
- Allergan
- 三菱 Pharma
- 鹽野義製藥
- Watson
- IVAX
- Alcon
- H Lundbeck
- Biogen Idec
- Mylan Labs
- Shire
- 小野藥品
- 田邊製藥
- 第一製藥
- Barr
- Gilead Sciences
- Purdue Pharma
Abstract
Partneringreview 2006 -- Volume 4: Stage of Development provides an in depth
view into the deals and alliances by development stage announced in 2005, in a
clear and accessible format. The report reviews over 2,600 deal
announcements from discovery stage deals to marketed -- the full list of
stages covered -- discovery, lead molecule, preclinical, phase I, phase I/II,
phase II, phase II/III, pre-registration, regulatory approval, marketing and
formulation stage deals. Each sector is further divided to analyze deals by
company, industry sector and therapy area. Every deal is fully
categorized, includes a detailed description, and includes financials such as
headline value, upfront and milestone payments, where disclosed.
Each deal is annotated with a deal number, such as #43. This number links to
the full deal in the deal listing at the rear of each report. When using the
PDF format in Acrobat Reader, simply click on the number to move around the
report.
All the year's deals at a glance.
Want to know what your competitors are doing? Want to benchmark your deals
against others in your therapeutic area or see how the finances of different
deal types compare? Partneringreview 2006 brings all the 2005's deals into
focus in one place.
Partneringreview is a comprehensive summary of the year's deal announcements
in a clear and accessible printable format. Every deal entry includes
financial information where disclosed, such as headline values and upfront and
milestone payments. A new addition of an overview of financings from investors
is also included in this latest edition.
Partneringreview 2006 is the full report of all the deals data collected in
2005, providing a broad perspective of deal announcements, and incorporates
all six volumes.
Table of Contents
INTRODUCTION
- About Partneringreview
- Full contents of Partneringreview 2006
- Review of deal making in 2005
- Deals announced by development stage
VOLUME 4: STAGE OF DEVELOPMENT
Chapter 1: Early stage -- discovery, lead and preclinical
- Deals in early stage by company
- Deals in early stage by industry focus
- Deals in early stage by therapy focus
Chapter 2: Clinical stage - phase I to Phase III
- Deals in clinical stage by company
- Deals in clinical stage by industry focus
- Deals in clinical stage by therapy focus
Chapter 3: Late stage -- registration, approval and marketed
- Deals in late stage by company
- Deals in late stage by industry focus
- Deals in late stage by therapy focus
Chapter 4: List of deals
GLOSSARY
Tables
- Table 1 Top early stage type dealmaking companies in 2005
- Table 2 Top clinical stage type dealmaking companies in 2005
- Table 3 Top late stage type dealmaking companies in 2005
Figures
- Fig. i.1 Deals announced by stage
- Fig. 1.1 Announcements in early stage by company
- Fig. 1.2 Announcements in early stage by industry sector
- Fig. 1.3 Announcements in early stage by therapy area
- Fig. 2.1 Announcements in clinical stage by company
- Fig. 2.2 Announcements in clinical stage by industry sector
- Fig. 2.3 Announcements in clinical stage by therapy area
- Fig. 3.1 Announcements in late stage by company
- Fig. 3.2 Announcements in late stage by industry sector
- Fig. 3.3 Announcements in late stage by therapy area
